SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017398
Filing Date
2022-08-15
Accepted
2022-08-15 16:47:02
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alna-20220630.htm   iXBRL 10-Q 3181987
2 EX-1.1 alna-ex1_1.htm EX-1.1 437761
3 EX-3.2 alna-ex3_2.htm EX-3.2 22000
4 EX-3.3 alna-ex3_3.htm EX-3.3 31297
5 EX-31.1 alna-ex31_1.htm EX-31.1 14604
6 EX-31.2 alna-ex31_2.htm EX-31.2 14592
7 EX-32.1 alna-ex32_1.htm EX-32.1 14970
  Complete submission text file 0000950170-22-017398.txt   9458413

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alna-20220630_pre.xml EX-101.PRE 339233
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alna-20220630.xsd EX-101.SCH 44995
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alna-20220630_cal.xml EX-101.CAL 37142
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alna-20220630_def.xml EX-101.DEF 237713
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alna-20220630_lab.xml EX-101.LAB 432058
56 EXTRACTED XBRL INSTANCE DOCUMENT alna-20220630_htm.xml XML 1307830
Mailing Address 142 -F NORTH ROAD, SUITE 150 SUDBURY MA 01776
Business Address 142 -F NORTH ROAD, SUITE 150 SUDBURY MA 01776 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38268 | Film No.: 221166305
SIC: 2836 Biological Products, (No Diagnostic Substances)